James Hengy, DO
Otolaryngology/Facial Plastic Surgery · Manistee, MINPI 1740248350
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medical Device Business Services, Inc. at 42.3% of the total. Reporting peaked in 2020 at $786 and has fallen 67.4% since, to $256 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in MI, where the typical reported total is $2,119.
Across 31 payments — averaging $49.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$645
- Acclarent, Inc$335
- Aerin Medical Inc.$147
- Stryker$130
- Integra Lifesciences Corporation$101
- Takeda Pharmaceuticals U.S.A., Inc.$41
- plus $127 from 5 others
What the payments were for
- Travel & lodging$64542%
- Food & beverage$84055%
- Education$413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $645 |
| Acclarent, Inc | 9 | $335 |
| Aerin Medical Inc. | 4 | $147 |
| Stryker | 4 | $130 |
| Integra Lifesciences Corporation | 2 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| GSK | 2 | $33 |
| Sanofi | 1 | $31 |
| Smith+Nephew | 1 | $11 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TruDi Nav Cable$104
How this compares
$1,526 in reported general payments places this provider in the 35th percentile of 31 otolaryngology/facial plastic surgery providers in Michigan.
See all otolaryngology/facial plastic surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 34 | $126,367 |
| Dupixent PenDupilumab | 14 | $53,452 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 65 | $44,254 |
| Epinephrine | 44 | $11,435 |
| Montelukast Sodium | 848 | $9,672 |
| Azelastine Hcl | 236 | $8,214 |
| Ipratropium Bromide | 169 | $7,781 |
| Mometasone Furoate | 68 | $6,041 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 32 | $5,126 |
| Pilocarpine Hcl | 80 | $4,929 |
| Fluticasone Propionate | 235 | $4,620 |
| Famotidine | 82 | $4,197 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 85 | $3,552 |
| Cefdinir | 138 | $2,685 |
| Levocetirizine Dihydrochloride | 132 | $1,618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $33 | $44,25465 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 31 otolaryngology/facial plastic surgery providers in Michigan.
Other otolaryngology/facial plastic surgery in Manistee
- Andrew MendiansManistee$2K
- Prasad ThottamWest Bloomfield$43K
- Ahmed SufyanEast Lansing$16K
- Warren BrandesMadison Heights$12K
- Amber BerryKalamazoo$9K
- Miles NeumannSouthfield$6K
- Kenneth GwinnShelby Township$5K
- Jason ChesneyEast Lansing$5K
- Christine LepoudreNovi$5K
- Mark TomaDearborn$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.